MedWatch Safety Alerts

Thinogenics Products by Nature’s Universe: Recall - Undeclared Drug Ingredient

Use of undeclared sibutramine can lead to increased risk of seizures, heart attacks, arrhythmia and stroke.

Learn More

Propofol Injectable Emulsion, USP by Hospira: Recall - Visible Particulates

Injected particulate matter may result in local inflammation, phlebitis, and/or low level allergic response through mechanical disruption of tissue or immune response to the particulate.

Learn More

S.W.A.G: Public Notification - Undeclared Drug Ingredient

Contains undeclared Sildenafil, which may interact with nitrates found in some prescription drugs such as nitroglycerin and may lower blood pressure to dangerous levels.

Learn More

Lidocaine HCI Injection, USP, by Hospira: Recall - Visible Particulates

Risk of local inflammation, and/or mechanical disruption of tissue or immune response to the particulate, and/or a delay in therapy.

Learn More

CUBICIN (daptomycin for injection) by Cubist Pharmaceuticals: Recall - Presence of Particulate Matter

Potential risk of thromboembolism, pulmonary emboli, phlebitis, mechanical block of the capillaries or arterioles, activation of platelets, subsequent generation of microthrombi, and emboli.

Learn More

Laparoscopic Power Morcellation in Hysterectomy and Myomectomy: FDA Safety Communication - Use Discouraged Due to Increased Risk in Women With Uterine Fibroids

If laparoscopic power morcellation is performed in women with unsuspected uterine sarcoma, there is a risk that the procedure will spread the cancerous tissue within the abdomen and pelvis.

Learn More

ARKON Anesthesia Delivery System with Version 2.0 Software by Spacelabs Healthcare: Class I Recall - Software Defect May Cause System to Stop Working

Defect may cause serious adverse health consequences, including hypoxemia and death.

Learn More

Call us toll-free at (800) 641-0098